Selected research
Market Structure
Global Acetylglucosamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Acetylglucosamine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Acetylglucosamine include YSK, Fengrun Biotech, Golden-shell, Aoxin-group, Rixing Biotech, Bio-gen Extracts, AdvoCare, Amicogen and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Acetylglucosamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Acetylglucosamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Acetylglucosamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acetylglucosamine market size, projected growth trends, production technologies, key applications, and end-use industries.
Acetylglucosamine Segment by Company
YSK
Fengrun Biotech
Golden-shell
Aoxin-group
Rixing Biotech
Bio-gen Extracts
AdvoCare
Amicogen
Merck KGaA
Carl Roth
Kaneka
Ethical Naturals
NOW Foods
Beloor Bayir
Vitaco Health
Pure Encapsulations
Kraeber & Co
Source Naturals
NutriCology
Acetylglucosamine Segment by Type
Extraction of the Shell
Microbial Fermentation
Acetylglucosamine Segment by Application
Cosmetics
Health Care Products
Drugs
Others
Acetylglucosamine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetylglucosamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acetylglucosamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetylglucosamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Acetylglucosamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acetylglucosamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acetylglucosamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Acetylglucosamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Extraction of the Shell
- Microbial Fermentation
Applications
- Cosmetics
- Health Care Products
- Drugs
- Others
Companies covered
- YSK
- Fengrun Biotech
- Golden-shell
- Aoxin-group
- Rixing Biotech
- Bio-gen Extracts
- AdvoCare
- Amicogen
- Merck KGaA
- Carl Roth
- Kaneka
- Ethical Naturals
- NOW Foods
- Beloor Bayir
- Vitaco Health
- Pure Encapsulations
- Kraeber & Co
- Source Naturals
- NutriCology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Acetylglucosamine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Acetylglucosamine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Acetylglucosamine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Acetylglucosamine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Acetylglucosamine Market Dynamics
- 2.1 Acetylglucosamine Industry Trends
- 2.2 Acetylglucosamine Industry Drivers
- 2.3 Acetylglucosamine Industry Opportunities and Challenges
- 2.4 Acetylglucosamine Industry Restraints
3 Acetylglucosamine Market by Manufacturers
- 3.1 Global Acetylglucosamine Revenue by Manufacturers (2021-2026)
- 3.2 Global Acetylglucosamine Sales by Manufacturers (2021-2026)
- 3.3 Global Acetylglucosamine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Acetylglucosamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Acetylglucosamine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Acetylglucosamine Manufacturers, Product Type & Application
- 3.7 Global Acetylglucosamine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Acetylglucosamine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Acetylglucosamine Players Market Share by Revenue in 2025
- 3.8.3 2025 Acetylglucosamine Tier 1, Tier 2, and Tier 3
4 Acetylglucosamine Market by Type
- 4.1 Acetylglucosamine Type Introduction
- 4.1.1 Extraction of the Shell
- 4.1.2 Microbial Fermentation
- 4.2 Global Acetylglucosamine Sales by Type
- 4.2.1 Global Acetylglucosamine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Acetylglucosamine Sales by Type (2021-2032)
- 4.2.3 Global Acetylglucosamine Sales Market Share by Type (2021-2032)
- 4.3 Global Acetylglucosamine Revenue by Type
- 4.3.1 Global Acetylglucosamine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Acetylglucosamine Revenue by Type (2021-2032)
- 4.3.3 Global Acetylglucosamine Revenue Market Share by Type (2021-2032)
5 Acetylglucosamine Market by Application
- 5.1 Acetylglucosamine Application Introduction
- 5.1.1 Cosmetics
- 5.1.2 Health Care Products
- 5.1.3 Drugs
- 5.1.4 Others
- 5.2 Global Acetylglucosamine Sales by Application
- 5.2.1 Global Acetylglucosamine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Acetylglucosamine Sales by Application (2021-2032)
- 5.2.3 Global Acetylglucosamine Sales Market Share by Application (2021-2032)
- 5.3 Global Acetylglucosamine Revenue by Application
- 5.3.1 Global Acetylglucosamine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Acetylglucosamine Revenue by Application (2021-2032)
- 5.3.3 Global Acetylglucosamine Revenue Market Share by Application (2021-2032)
6 Global Acetylglucosamine Sales by Region
- 6.1 Global Acetylglucosamine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Acetylglucosamine Sales by Region (2021-2032)
- 6.2.1 Global Acetylglucosamine Sales by Region (2021-2026)
- 6.2.2 Global Acetylglucosamine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Acetylglucosamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Acetylglucosamine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Acetylglucosamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Acetylglucosamine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Acetylglucosamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Acetylglucosamine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Acetylglucosamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Acetylglucosamine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Acetylglucosamine Revenue by Region
- 7.1 Global Acetylglucosamine Revenue by Region
- 7.1.1 Global Acetylglucosamine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Acetylglucosamine Revenue by Region (2021-2026)
- 7.1.3 Global Acetylglucosamine Revenue by Region (2027-2032)
- 7.1.4 Global Acetylglucosamine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Acetylglucosamine Revenue (2021-2032)
- 7.2.2 North America Acetylglucosamine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Acetylglucosamine Revenue (2021-2032)
- 7.3.2 Europe Acetylglucosamine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Acetylglucosamine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Acetylglucosamine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Acetylglucosamine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Acetylglucosamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 YSK
- 8.1.1 YSK Company Information
- 8.1.2 YSK Business Overview
- 8.1.3 YSK Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 YSK Acetylglucosamine Product Portfolio
- 8.1.5 YSK Recent Developments
- 8.2 Fengrun Biotech
- 8.2.1 Fengrun Biotech Company Information
- 8.2.2 Fengrun Biotech Business Overview
- 8.2.3 Fengrun Biotech Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fengrun Biotech Acetylglucosamine Product Portfolio
- 8.2.5 Fengrun Biotech Recent Developments
- 8.3 Golden-shell
- 8.3.1 Golden-shell Company Information
- 8.3.2 Golden-shell Business Overview
- 8.3.3 Golden-shell Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Golden-shell Acetylglucosamine Product Portfolio
- 8.3.5 Golden-shell Recent Developments
- 8.4 Aoxin-group
- 8.4.1 Aoxin-group Company Information
- 8.4.2 Aoxin-group Business Overview
- 8.4.3 Aoxin-group Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Aoxin-group Acetylglucosamine Product Portfolio
- 8.4.5 Aoxin-group Recent Developments
- 8.5 Rixing Biotech
- 8.5.1 Rixing Biotech Company Information
- 8.5.2 Rixing Biotech Business Overview
- 8.5.3 Rixing Biotech Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Rixing Biotech Acetylglucosamine Product Portfolio
- 8.5.5 Rixing Biotech Recent Developments
- 8.6 Bio-gen Extracts
- 8.6.1 Bio-gen Extracts Company Information
- 8.6.2 Bio-gen Extracts Business Overview
- 8.6.3 Bio-gen Extracts Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Bio-gen Extracts Acetylglucosamine Product Portfolio
- 8.6.5 Bio-gen Extracts Recent Developments
- 8.7 AdvoCare
- 8.7.1 AdvoCare Company Information
- 8.7.2 AdvoCare Business Overview
- 8.7.3 AdvoCare Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AdvoCare Acetylglucosamine Product Portfolio
- 8.7.5 AdvoCare Recent Developments
- 8.8 Amicogen
- 8.8.1 Amicogen Company Information
- 8.8.2 Amicogen Business Overview
- 8.8.3 Amicogen Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Amicogen Acetylglucosamine Product Portfolio
- 8.8.5 Amicogen Recent Developments
- 8.9 Merck KGaA
- 8.9.1 Merck KGaA Company Information
- 8.9.2 Merck KGaA Business Overview
- 8.9.3 Merck KGaA Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck KGaA Acetylglucosamine Product Portfolio
- 8.9.5 Merck KGaA Recent Developments
- 8.10 Carl Roth
- 8.10.1 Carl Roth Company Information
- 8.10.2 Carl Roth Business Overview
- 8.10.3 Carl Roth Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Carl Roth Acetylglucosamine Product Portfolio
- 8.10.5 Carl Roth Recent Developments
- 8.11 Kaneka
- 8.11.1 Kaneka Company Information
- 8.11.2 Kaneka Business Overview
- 8.11.3 Kaneka Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Kaneka Acetylglucosamine Product Portfolio
- 8.11.5 Kaneka Recent Developments
- 8.12 Ethical Naturals
- 8.12.1 Ethical Naturals Company Information
- 8.12.2 Ethical Naturals Business Overview
- 8.12.3 Ethical Naturals Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Ethical Naturals Acetylglucosamine Product Portfolio
- 8.12.5 Ethical Naturals Recent Developments
- 8.13 NOW Foods
- 8.13.1 NOW Foods Company Information
- 8.13.2 NOW Foods Business Overview
- 8.13.3 NOW Foods Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 NOW Foods Acetylglucosamine Product Portfolio
- 8.13.5 NOW Foods Recent Developments
- 8.14 Beloor Bayir
- 8.14.1 Beloor Bayir Company Information
- 8.14.2 Beloor Bayir Business Overview
- 8.14.3 Beloor Bayir Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Beloor Bayir Acetylglucosamine Product Portfolio
- 8.14.5 Beloor Bayir Recent Developments
- 8.15 Vitaco Health
- 8.15.1 Vitaco Health Company Information
- 8.15.2 Vitaco Health Business Overview
- 8.15.3 Vitaco Health Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Vitaco Health Acetylglucosamine Product Portfolio
- 8.15.5 Vitaco Health Recent Developments
- 8.16 Pure Encapsulations
- 8.16.1 Pure Encapsulations Company Information
- 8.16.2 Pure Encapsulations Business Overview
- 8.16.3 Pure Encapsulations Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Pure Encapsulations Acetylglucosamine Product Portfolio
- 8.16.5 Pure Encapsulations Recent Developments
- 8.17 Kraeber & Co
- 8.17.1 Kraeber & Co Company Information
- 8.17.2 Kraeber & Co Business Overview
- 8.17.3 Kraeber & Co Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Kraeber & Co Acetylglucosamine Product Portfolio
- 8.17.5 Kraeber & Co Recent Developments
- 8.18 Source Naturals
- 8.18.1 Source Naturals Company Information
- 8.18.2 Source Naturals Business Overview
- 8.18.3 Source Naturals Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Source Naturals Acetylglucosamine Product Portfolio
- 8.18.5 Source Naturals Recent Developments
- 8.19 NutriCology
- 8.19.1 NutriCology Company Information
- 8.19.2 NutriCology Business Overview
- 8.19.3 NutriCology Acetylglucosamine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 NutriCology Acetylglucosamine Product Portfolio
- 8.19.5 NutriCology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Acetylglucosamine Value Chain Analysis
- 9.1.1 Acetylglucosamine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Acetylglucosamine Production Mode & Process
- 9.2 Acetylglucosamine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Acetylglucosamine Distributors
- 9.2.3 Acetylglucosamine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst